4/8 one carbon metabolism

Cards (45)

  • FOLIC ACID
    • coenzyme: tetrahydrofolate
    • typical reactions type: thymine synthesis
    • consequences of deficiency: anemia, neural tube defects in development
    folate = critical for 1c unit rxns
  • sources of folic acid
    • naturally many foods: beans, peas, asparagus, eggs, leafy greens, beets, citrus fruits, Brussel sprouts, broccoli, nuts and seeds
    • It is also added to foods and sold as a supplement
  • FOLIC ACID IS MADE UP OF WHAT 3 COMPONENTS?
    - PTERIDINE RING, P AMINO BENZOATE (PABA), GLUTAMATE
  • FOLIC ACID BECOMES POLYGLUTAMATED
    • reduces their affinity for transporter
    • enhances affinity for folate enzymes
  • if u r pregnant and have a folic acid deficiency....THIS INCREASES RISK OF NEURAL TUBE DEFECTS
  • TETRAHYDROFOLATE (coenzyme form)
    • carrier for one carbon (1c) units in different oxidative states
    • FOLIC ACID SEQUENTIALLY REDUCED TO FIRST DIHYDROFOLATE (DHF) AND THEN THF
    • **folic acid has to be converted to tetrahydrofolate (THF)
    • how? via enzyme DHFR (DIHYDROFOLATE REDUCTASE)
  • table:
    most reduced= methanol
    intermediate = formaldehyde
    most oxidized = formic acid
  • one carbon units attach to tetrahydrofolate in an interconvertible manner . n5 or n10
  • what is the process of modifying tetrahydrofolate called?
    folate cycle
    • compartmentalized
    • occurs in BOTH cytoplasm and mitochondria within cells
    • One carbon units are loaded onto THF and converted into usable forms for biosynthetic processes
  • tetrahydrofolate is critical in de novo synthesis of glycine
  • Serine is the precursor of glycine
    • In the formation of glycine, the side-chain methylene group of serine is transferred to tetrahydrofolate.
    catalyzed by the PLP enzyme serine hydroxymethyltransferase (SHMT1 or SHMT2)
  • 3-phosphoglycerate is the precursor of serine synthesis
    • Serine is synthesized from the glycolytic intermediate 3-phosphoglycerate.
    • 3-Phosphoglycerate is oxidized to 3-phosphohydroxypyruvate, transaminated to 3-phosphoserine, and hydrolyzed to serine.
  • liquid chromatography- mass spectrometry (LC-MS)
    1. collection
    2. extraction
    3. injection
    4. LC separation via HILIC column
    5. ionization and detection by Q EXACTIVE PLUS MS INSTRUMENT
    6. MS SPECTRUM
    7. quantification
  • inhibiting SHMT1/2 elevates glycine levels
    • as glycine levels go down, serine levels go up

    serine is precursor of glycine. side chain methylene group of serine is transferred to tetrahydrofolate... catalyzed by SHMT1 (serine hydroxymethyltransferase)
  • REVERSE SHMT flux is required for whole body glycine clearance.
    • if SHMT1/2 blocked, consumption decreases...production increases ... glycine levels increases bc it is not being cleared

    reaction: SERINE ---SHMT1/2---> GLYCINE
    SERINE <-------------GLYCINE

    REVERSIBLE REACTION :
    If SHMT is blocked: S CANT CONVERT TO G MEANING LESS G AND MORE S
  • glycine is also cleared by glycine cleavage system
    • series of 4 enzymes that converts glycine --> co2 and 5,10-me THF
    • active in liver
    • critical source of 1-C units in early development
  • both SHMT and glycine cleavage system are major contributors to glycine clearance.
    • glycine cleavage system was thought to be the major pathway of glycine clearance in mammals
    • SHMT2 or a major enzyme of the glycine cleavage system ELEVATE glycine levels in mouse models
  • A one-carbon unit is required for the synthesis of methionine
  • Methionine cycle is coupled to folate cycle.
  • methionine is an essential amino acid bc the full carbon backbone cant be synthesized so needs to be obtained from diet
  • S-Adenosylmethionine is the major donor of methyl groups
    S-adenosylmethionine (SAM) = an activated methyl donor with higher transfer potential than tetrahydrofolate
    – synthesized from methionine and ATP
  • Methylation by SAM is a critical modification for numerous biological functions.
    • generally repressive of gene expression
    • either promote or repress gene expression depending on the chromatin structure and recruitment of other proteins (i.e. transcription factors)
    • methylation of RNA, typically on adenine, can influence splicing, stability, nuclear export, translation, and other properties
    • methylation proteins can play important regulatory roles by influencing structure
  • S-Adenosylmethionine is converted to homocysteine.
    • After donation of a methyl group by S-adenosylmethionine, the resulting S- adenosylhomocysteine is hydrolyzed, yielding adenosine and homocysteine.
  • Regeneration of methionine
    • Methionine is regenerated by transfer of a methyl group to homocysteine from N5-methyltetrahydrofolate.
    – catalyzed by methionine synthase
    – mediated by the coenzyme methylcobalamin, which is derived from vitamin B12
  • deficiency of vitamin B12 or folic acid can lead to increased homocysteine levels.
  • High homocysteine levels correlate with vascular disease
    • Elevated serum levels of homocysteine or the disulfide-linked dimer homocystine are a predisposing factor for coronary heart disease and arteriosclerosis.
    • Elevated homocysteine levels can also result from mutations in the gene encoding cystathionine β-synthase.
    • High levels of homocysteine:
    – damage cells lining blood vessels.
    – increase the growth of vascular smooth muscle.
    – raise oxidative stress.
    – are implicated in the development of type 2 diabetes.
  • Formation of S-adenosylmethionine activates the methyl group of methionine, which the folate cycle restores.
  • Nucleotides can be synthesized by de novo or salvage pathways
    • Nucleotides are key biomolecules.
    – Activated precursors of nucleic acids.
    ATP is the universal currency of energy.
    GTP serves as an energy source.
    – Nucleotide derivatives participate in biosynthetic processes.
    CyclicAMP and cyclicGMP are essential components of signal- transduction pathways.
    – ATP acts as the donor of phosphoryl groups transferred by protein kinases.
  • Nucleotides can be synthesized by de novo and salvage pathways.
    DE NOVO: activated ribose (PRPP) + amino acids + ATP + CO2 --> nucleotide
    SALVAGE PATHWAY: activated ribose (PRPP) + base --> nucleotide
  • De novo and salvage pathways use different starting material for nucleotide synthesis.
    De novo pathways = pathways in which nucleobases are assembled from scratch.
    – For pyrimidines, the framework for the base is assembled first and then attached to ribose.
    – For purines, the base is synthesized piece by piece directly onto a ribose-based structure.
    Salvage pathways = pathways in which preformed bases are recovered and reconnected to a ribose unit.
  • The pyrimidine ring is assembled de novo from CO2, ammonia, and aspartate.
    • Pyrimidine rings are assembled from bicarbonate, aspartate, and ammonia.
    • Glutamine often serves as an ammonia donor.
  • The formation of PRPP
    • 5-phosphoribosyl-1-pyrophosphate (PRPP) = a form of ribose activated to accept nucleobases
    • synthesized by 5-Phosphoribosyl-1-pyrophosphate synthetase
  • Glutamine provides the nitrogen via ammonia for the committed step in purine synthesis
    • Purine bases are assembled already attached to the ribose ring.
    • The committed step in purine biosynthesis forms 5-phosphoribosyl-1-amine from PRPP and glutamine.
    – catalyzed by glutamine phosphoribosyl amidotransferase
  • Purine nucleotide synthesis require one- carbon units from the folate cycle.
  • Two of the enzymes in the de novo purine biosynthesis pathway require 10-formyl-THF.
  • The first chemotherapeutic agents were antifolates.
    • 16 children with acute lymphoblastic leukaemia (AML) with aminopterin, an amino derivative of folic acid.
    • 10 of the patients resulted in temporary remission.
    • This trial was considered the first ever successful remission of leukaemia and the foundation of modern chemotherapy.
    • Aminopterin was later later developed to methotrexate which is less toxic and is commonly used today in chemotherapy treatment.
  • Methotrexate is a folic acid derivative
    • A chemotherapeutic agent in many types of cancer
    • An immunosuppressant used to used to treat inflammatory conditions, including rheumatoid arthritis.
  • Methotrexate is a DHFR inhibitor
    • Methotrexate inhibits dihydrofolate reductase (DHFR)
    • This prevents generation of THF to carry one-carbon units for purine synthesis
  • Many different chemical forms of antifolates target different enzymes.
  • Serine and glycine are required for purine nucleotide synthesis.